Shopping Cart
- Remove All
- Your shopping cart is currently empty
CEP-11981 (ESK981; BOL 303213X) is an orally active tyrosine kinase inhibitor (TKI) targeting TIE2, VEGFR1-3, and FGFR1, exhibiting potential anti-tumor and anti-angiogenic effects.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,720 | 10-14 weeks | |
50 mg | $3,580 | 10-14 weeks | |
100 mg | $4,900 | 10-14 weeks |
Description | CEP-11981 (ESK981; BOL 303213X) is an orally active tyrosine kinase inhibitor (TKI) targeting TIE2, VEGFR1-3, and FGFR1, exhibiting potential anti-tumor and anti-angiogenic effects. |
In vivo | Calcium channel-modulator-1 (20 mg/kg ; p.o.) causes a 35-37% decrease in systolic blood pressure in spontaneously hypertensive rats. However, iv administration of Calcium channel-modulator-1 to anesthetized spontaneously hypertensive rats causes a decrease in blood pressure.[1] |
Alias | ESK981 ; BOL 303213X, ESK981, BOL 303213X |
Molecular Weight | 477.56 |
Formula | C28H27N7O |
Cas No. | 856691-93-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.